4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001415889-24-007332
Options or other derivatives
- Director acquired 94,441 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Haddadin Yezan Munther Director | 2024-03-07 | Grant or award · Stock Option (Right to Buy) | +94,441 | 94,441 | D | ||
Loading xslF345X05/form4-03082024_090358.xml…